Ocrelizumab, and Treating Primary Progressive Multiple Sclerosis

preview_player
Показать описание
Clyde Markowitz, MD, discusses ocrelizumab's role as the first foot in the door to PPMS treatment at the 2017 Consortium of Multiple Sclerosis Centers in New Orleans.
Рекомендации по теме